B Lymphocyte Signaling Established by the CD19/CD22 Loop Regulates Autoimmunity in the Tight-Skin Mouse
- 31 August 2004
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 165 (2), 641-650
- https://doi.org/10.1016/s0002-9440(10)63328-7
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Sialic Acid Binding Domains of CD22 Are Required For Negative Regulation of B Cell Receptor SignalingThe Journal of Experimental Medicine, 2002
- The Ligand-binding Domain of CD22 Is Needed for Inhibition of the B Cell Receptor Signal, as Demonstrated by a Novel Human CD22-specific Inhibitor CompoundThe Journal of Experimental Medicine, 2002
- Interleukin 4 Reduces Expression of Inhibitory Receptors on B Cells and Abolishes CD22 and FcγRII-mediated B Cell SuppressionThe Journal of Experimental Medicine, 2002
- CD19 Amplification of B Lymphocyte Ca2+ ResponsesOnline Journal of Public Health Informatics, 2001
- Lack of Skin Fibrosis in Tight Skin (TSK) Mice with Targeted Mutation in the Interleukin-4Rα and Transforming Growth Factor-β GenesJournal of Investigative Dermatology, 2001
- Regulation of Connective Tissue Synthesis in Systemic SclerosisInternational Reviews of Immunology, 1995
- Induction of Skin Fibrosis and Autoantibodies by Infusion of Immunocompetent Cells from Tight Skin Mice into C57BL/6 Pa/Pa MiceJournal of Autoimmunity, 1993
- CD19: Lowering the Threshold for Antigen Receptor Stimulation of B LymphocytesScience, 1992
- Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1988
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisArthritis & Rheumatism, 1988